Oct 13, 2022
Dr. Otoño Silva of Interventional Orthopedics of Washington announced the launch of a medical weight loss program that allows patients to lose 10-15% of their body weight safely and without restrictive diets or strenuous exercise.

Bellevue,United States - October 13, 2022 /PressCable/ —
Patients can now benefit from a safe medical weight loss program from Bellevue-based Interventional Orthopedics of Washington. Dr. Otoño Silva has launched FDA-approved Semaglutide injections that have resulted in significant body weight loss in those who are overweight or morbidly obese.
Interested parties can learn more at https://iowmed.com/weight-loss
As a result of his new weight loss program, Dr. Silva’s patients can now lose an average of 10% of their total body weight The FDA-approved drug, Semaglutide, mimics glucagon-like peptide-1 (GLP-1), a hormone that affects parts of the brain that control hunger and food intake.
While it is used to treat type 2 diabetes, Semaglutide acts as an appetite suppressant, reducing hunger pangs while increasing satiety – the cornerstones of weight loss. Semaglutide has been approved for use in managing weight in adults who are obese or overweight, together with a low-calorie diet and increased physical activity. This once-weekly subcutaneous injection has been approved as the first drug to manage weight in people with general obesity since 2014.
GLP-1s regulate blood sugar levels by raising insulin and lowering glucagon. By enhancing muscle cells’ sensitivity to insulin and controlling the growth of fat cells, GLP-1s help enhance the body’s overall energy metabolism.
42.4% of American adults are currently obese, according to the CDC and the Department of Health and Human Services. This is a significant increase from the 30.5% estimated in 2000. According to the FDA, around 70% of Americans are overweight. The medical weight loss program at Interventional Orthopedics of Washington uses Semaglutide to directly affect weight loss. Consultations with Dr. Silva will include a review of a patient’s medical condition and treatment options, education about weight loss and lifestyle changes, and a clear overview of the Semaglutide treatment.
Dr. Silva commented: “Obesity and being overweight are associated with chronic problems, poor health outcomes, inflammation, pain concerns, and most diseases, so finding a healthy way to lose extra weight may be the greatest thing to do right now to enhance overall health and wellbeing. Patients who successfully finish the program report losing, on average, 10-15% of their body weight, allowing them to live longer and healthier lives without having to drastically change their lifestyle.”
For more information, visit: https://iowmed.com/weight-loss
Contact Info:
Name: Otoño Silva, MD
Email: Send Email
Organization: Interventional Orthopedics of Washington
Address: 1515 116th Ave NE Suite 202, Bellevue, WA 98004, United States
Phone: +1-425-326-1665
Website: https://iowmed.com
Source: PressCable
Release ID: 89083176
If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 8 hours.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.